-
Mashup Score: 0Study provides roadmap for using convalescent plasma as an effective COVID-19 treatment - 1 year(s) ago
A new analysis shows how convalescent plasma can be used to prevent hospitalizations and ultimately save lives, both for COVID-19 and for the next viral pandemic that inevitably arrives.
Source: Brown UniversityCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 6Study Finds Ivermectin Does Not Reduce COVID-19 Disease Severity - 2 year(s) ago
A study of patients at high risk of severe COVID-19 disease progression found ivermectin was no more effective than standard care at preventing adverse outcomes.
Source: Contagion LiveCategories: Infectious Disease, Latest HeadlinesTweet-
"Among the high-risk cohort with comorbidities, #ivermectin as a treatment during early COVID-19 infection did not prevent severe disease progression." #IDTwitter #COVIDtreatment https://t.co/Wcq9gH4Uks
-
-
Mashup Score: 0Are laboratory-made, COVID-19-specific monoclonal antibodies an effective treatment for COVID-19? - 3 year(s) ago
Hello, I’m Monaz Mehta, editor in the Cochrane Editorial and Methods department. Cochrane is producing a series of reviews to help decision makers respond to the COVID-19 pandemic. In September 2021, we published the first version of a Living Systematic Review on the effects of monoclonal antibodies for treating COVID-19 and in this podcast we speak to Nina Kreuzberger one of the…
Source: www.cochrane.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet-
#CochranePodcast - Are laboratory-made, #COVID19 -specific monoclonal #antibodies an effective #COVIDtreatment? 🎧 https://t.co/W2e5cK9Vxm Hear from one of the lead authors of the Living #SystematicReview (📃 https://t.co/wnjNfITiQ5). Available on our website, #Spotify, & #iTunes https://t.co/0bnWb9Tfss
-
-
Mashup Score: 3Are laboratory-made, COVID-19-specific monoclonal antibodies an effective treatment for COVID-19? - 3 year(s) ago
Hello, I’m Monaz Mehta, editor in the Cochrane Editorial and Methods department. Cochrane is producing a series of reviews to help decision makers respond to the COVID-19 pandemic. In September 2021, we published the first version of a Living Systematic Review on the effects of monoclonal antibodies for treating COVID-19 and in this podcast we speak to Nina Kreuzberger one of the…
Source: www.cochrane.orgCategories: General Medicine News, Latest HeadlinesTweet-
#CochranePodcast - Are laboratory-made, #COVID19 -specific monoclonal #antibodies an effective #COVIDtreatment? 🎧 https://t.co/4gKcoyRqbS Hear from one of the lead authors of the Living #SystematicReview (📃 https://t.co/aBEtJpsUEv). Available on our website, #Spotify, & #iTunes https://t.co/JL1WPQLf2K
-
-
Mashup Score: 13Is plasma from people who have recovered from COVID-19 an effective treatment for people with COVID-19? - 3 year(s) ago
Monaz: Hello, I’m Monaz Mehta, editor in the Cochrane Editorial and Methods department. Cochrane is producing a series of reviews to help decision makers respond to the COVID-19 pandemic. We’re keeping these reviews up to date as new evidence emerges and are now on the fourth version of our living review of convalescent plasma and hyperimmune immunoglobulin for COVID-19 patients, which was…
Source: www.cochrane.orgCategories: General Medicine News, Latest HeadlinesTweet-
Is #plasma from people who have recovered from #COVID19 an effective #COVIDTreatment ? 👂Listen to the podcast https://t.co/P23OuEqIwt 🤓read the full @CochraneHaem review https://t.co/01ErWyqkYr https://t.co/amD3vmiW64
-
-
Mashup Score: 6
Synthetic peptides that mimic human antibodies for COVID-19 could be cheaper and easier to produce
Source: Scientific AmericanCategories: Healthcare Professionals, Latest HeadlinesTweet-
This new treatment from @UWproteindesign uses a synthetic peptide that acts like an antibody to protect patients from #COVID19. An added benefit is that this could be easier to produce on a large scale. #COVIDtreatment #coronavirus @FoxNews https://t.co/aHHU8sZVaf
-
-
Mashup Score: 0
Baricitinib plus corticosteroids, compared to corticosteroids alone, was associated with improved pulmonary function in patients with COVID-19 pneumonia.
Source: Docwire NewsCategories: General Medicine News, Latest HeadlinesTweet-
Corticosteroids Combined with Baricitinib Improves #COVID-19 Pneumonia #coronavirus #COVIDtreatment https://t.co/h76ClQ5b9x
-
-
Mashup Score: 0San Diego Immunologist Gets $6.4 Million Grant for COVID-19 Antibody Research - Times of San Diego - 4 year(s) ago
The federal government awarded $6.4 million to Dr. Erica Ollmann Saphire, a professor at La Jolla Institute for Immunology, to support COVID-19 research.
Source: Times of San DiegoCategories: Healthcare Professionals, Latest HeadlinesTweet-
It will be exciting to see the future results of this forthcoming research on #COVID19 antibody therapy. #covidtreatment #immunology #antibodies @NIAIDNews @ljiresearch https://t.co/28tXqp2PZq
-
-
Mashup Score: 9Medical care for very ill COVID-19 patients is getting better - 4 year(s) ago
You’re better off being hospitalized now than four months ago, and hopefully, more research will lead to improvements in coronavirus treatments.
Source: USA TODAYCategories: Healthcare Professionals, Latest HeadlinesTweet-
While we wait for the #COVIDvaccine to be developed, it's encouraging to see rapid improvement in therapeutics for #COVID19 patients. #COVID #COVIDtreatment https://t.co/Fgq9A4B78E
-
-
Mashup Score: 2Medical care for very ill COVID-19 patients is getting better - 4 year(s) ago
You’re better off being hospitalized now than four months ago, and hopefully, more research will lead to improvements in coronavirus treatments.
Source: USA TODAYCategories: Healthcare Professionals, Latest HeadlinesTweet-
While we wait for the #COVIDvaccine to be developed, it's encouraging to see rapid improvement in therapeutics for #COVID19 patients. #COVID #COVIDtreatment https://t.co/Fgq9A4B78E
-
Study provides roadmap for using #convalescentplasma as an effective #COVIDtreatment | Adam C Levine, MD, et al. @BrownUniversity @BrownMedicine https://t.co/TtyAARiWmt